HLB Group Chairman Jin Yanggon Buys Stake in HLB Genex
Jin Yang-gon, chairman of HLB Group, has begun buying shares in HLB Genex.
According to HLB Group, Epoke, a financial investment company in which Chairman Jin holds a 99% stake, purchased 207,897 HLB Genex shares on the market from October 6 to 14. Following the purchases, Epoke's holdings in HLB Genex increased from 326,583 shares to 534,480 shares.
Earlier, Epoke purchased 218,718 HLB Innovation shares and 130,584 HLB Therapeutics shares on the market, respectively, from September 23 to October 1.
Chairman Jin has also continued to buy shares in his own name. Since the beginning of this year, he has purchased a total of 1,224,029 shares on the market across six affiliates: HLB Innovation, HLB Panagene, HLB Therapeutics, HLB Genex, HLB Biostep, and HLB Pep.
Hot Picks Today
"Samsung Electronics at 70,000 won, SK hynix at 200,000 won"... Why the gloomy outlook despite 'record-breaking earnings'?
- "I Was Just Going Barefoot at Home"... "Absolutely Not": Why Doctors Warn Against It
- "There's a Drink Like This?"... Chinese Beverage With "Korean" in Its Name Rakes in 85 Million Won in Monthly Sales
- "To Make His Girlfriend Think It Was His": Why He Demolished Someone Else's 2-Billion-Won Apartment
- "No Need to Hire a Model"... The 25-Year-Old Woman Who Entered Social Media with a Face That Cost Just 1,500 Won [AI Content: The Bright and Dark Sides] 1
An HLB Group official said, "Chairman Jin's sustained and repeated share purchases demonstrate through direct investment his confidence in the future growth of the group and its affiliates. They reflect his commitment to supporting the affiliates' growth from a long-term perspective, strengthening responsible management, and increasing both corporate and shareholder value."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
